tiprankstipranks
Trending News
More News >
Immuron Ltd (IMRN)
NASDAQ:IMRN
Advertisement

Immuron (IMRN) Similar Stocks

Compare
204 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immuron
$2.10
$16.69M
-3.76
9.38%
0 Buy
0 Hold
0 Sell
Hold
Can-Fite BioPharma
$0.44
$15.75M
-80.66%
0 Buy
0 Hold
0 Sell
Moderate Sell
Lipocine
$2.92
$14.90M
-50.37%
1 Buy
0 Hold
0 Sell
Moderate Buy
Adaptimmune Therapeutics
$0.06
-92.70%
BioVie
$1.80
$14.17M
-0.13
-93.66%
1 Buy
0 Hold
0 Sell
Moderate Buy
Aspire Biopharma Holdings
$0.39
$15.60M
-96.56%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMRN
Immuron
2.10
0.18
9.38%
CANF
Can-Fite BioPharma
0.44
-1.83
-80.62%
LPCN
Lipocine
2.69
-2.73
-50.37%
ADAP
Adaptimmune Therapeutics
0.05
-0.65
-92.86%
BIVI
BioVie
1.80
-26.60
-93.66%
ASBP
Aspire Biopharma Holdings
0.39
-11.05
-96.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis